First gene therapy operation for macular degeneration is a success

by The Medical News • 2019/02/20 • 0 Comments

A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.

← Newly released national framework identifies obstacles to improving EMS systems

Ocular Therapeutix™ Announces Dosing of First Patient in OTX-TKI (tyrosine kinase inhibitor implant) Phase 1 Clinical Trial for the Treatment of Wet Age-related Macular Degeneration (AMD) →